43 results
8-K
EX-99.1
HRMY
Harmony Biosciences Holdings Inc
30 Apr 24
WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year
7:45am
and neuronal connections, and results in a spectrum of intellectual disabilities and behavioral symptoms, such as social avoidance and irritability. While … , including anxiety, social withdrawal, ADHD, cognitive impairment and autism spectrum disorder. It is estimated that 22q occurs in one in 4,000 live births
8-K
EX-99.1
HRMY
Harmony Biosciences Holdings Inc
22 Feb 24
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
7:45am
of intellectual disabilities and behavioral symptoms, such as social avoidance and irritability. While the exact prevalence is unknown, upwards of 80,000
8-K
EX-99.1
HRMY
Harmony Biosciences Holdings Inc
31 Oct 23
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
7:45am
, and results in a spectrum of intellectual disabilities and behavioral symptoms, such as social avoidance and irritability. There are approximately 80,000 people
SC TO-T/A
EX-99
k45c9zigykvid9j br5x
11 Oct 23
Third party tender offer statement (amended)
8:31am
8-K
EX-99.1
ovqbhdmhllav30w
11 Oct 23
Harmony Biosciences Completes Acquisition of Zynerba
8:15am
8-K/A
EX-2.1
d98viu8
14 Sep 23
Entry into a Material Definitive Agreement
4:42pm
SC TO-T
EX-99
3b9v18xuoyy3k
28 Aug 23
Third party tender offer statement
8:23am
SC TO-T
EX-99
tcrnp pzx
28 Aug 23
Third party tender offer statement
8:23am
SC TO-C
EX-2.1
7qvl3
14 Aug 23
Information about tender offer
5:29pm
SC TO-C
EX-99.2
padaj
14 Aug 23
Information about tender offer
5:29pm
8-K
EX-2.1
7zh7w wbsn31ila2ge
14 Aug 23
Tender and Support Agreement
5:27pm
8-K
EX-99.2
t0nh4xd
14 Aug 23
Tender and Support Agreement
5:27pm
SC TO-C
EX-99.2
abbhyymfxlw
14 Aug 23
Information about tender offer
5:26pm
SC TO-C
EX-99.1
eo7unoqp6
14 Aug 23
Information about tender offer
5:26pm
8-K
EX-10.1
mnrkyoowz4r
27 Jul 23
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
h0s5ufbq7qske52
24 Apr 23
Harmony Biosciences Announces Jeffrey M. Dayno, M.D. Appointed President & Chief Executive Officer
8:30am